Table 5 Cox regression analysis to assess risk of anti-HCV seroconversion in patients undergoing hemodialysis therapy*
Risk Factors | N (%) | Anti-HCV + (%) | Adjusted Hazard Ratio (CI95%) | P |
|---|---|---|---|---|
Time on HDT* | ||||
Up to 4 years | 269 (74.7) | 25 (62.5) | 1 | - |
> 4 years | 91 (25.3) | 15 (37.5) | 2.2 (1.1–4.6) | 0.027 |
Unit Groups | ||||
A (4,5,6) | 201 (55.8) | 2 (5) | 1 | - |
B (1,2,3) | 159 (44.2) | 38 (95) | 42.4 (9.9–180.5) | 0.000 |